IWA
FLNA

IVC Wealth Advisors’s Filana Therapeutics FLNA Stock Holding History

IVC Wealth Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,673
Closed -$373K – 164
2024
Q3 		$373K Sell
12,673
-700
-5% -$16.1K 0.2% 99
2024
Q2 		$165K Hold
13,373
– – 0.09% 162
2024
Q1 		$271K Hold
13,373
– – 0.16% 134
2023
Q4 		$301K Sell
13,373
-2,925
-18% -$61.8K 0.19% 110
2023
Q3 		$271K Hold
16,298
– – 0.18% 115
2023
Q2 		$400K Buy
16,298
+2,600
+19% +$62.6K 0.25% 95
2023
Q1 		$330K Sell
13,698
-1,600
-10% -$44.3K 0.23% 100
2022
Q4 		$452K Buy
15,298
+483
+3% +$17.4K 0.33% 75
2022
Q3 		$620K Buy
14,815
+400
+3% +$10.8K 0.5% 59
2022
Q2 		$405K Buy
14,415
+125
+0.9% +$3.16K 0.31% 78
2022
Q1 		$531K Buy
14,290
+1,715
+14% +$72.7K 0.35% 67
2021
Q4 		$550K Buy
12,575
+2,700
+27% +$142K 0.35% 73
2021
Q3 		$613K Sell
9,875
-20
-0.2% -$1.67K 0.42% 61
2021
Q2 		$845K Buy
9,895
+3,025
+44% +$162K 0.59% 47
2021
Q1 		$309K Buy
+6,870
New +$270K 0.24% 95

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

IVC Wealth Advisors's FLNA Position: Q4 2024 in Review

IVC Wealth Advisors sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 12,673 shares — an estimated $373K sold.

IVC Wealth Advisors first reported a position in FLNA in Q1 2021 and held it in 15 quarters. The position peaked at $845K in Q2 2021. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • IVC Wealth Advisors reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • IVC Wealth Advisors sold 12,673 Filana Therapeutics shares in Q4 2024, an estimated $373K.
  • IVC Wealth Advisors first reported a position in Filana Therapeutics in Q1 2021 and held it in 15 quarters.
  • IVC Wealth Advisors's Filana Therapeutics position peaked at $845K in Q2 2021.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on IVC Wealth Advisors's 13F filing for Q4 2024, filed 17 Jan 2025.